Monoclonal antibody M195-Y-90Alternative Names: Anti-CD33 Yttrium-90-labelled monoclonal antibody; Yttrium-90-labelled human M195 monoclonal antibody
Latest Information Update: 05 Nov 2002
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Immunotherapies; Monoclonal antibodies; Radiopharmaceuticals
- Mechanism of Action CD33 antigen inhibitors; Ionising radiation emitters
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Acute myeloid leukaemia; Cancer